Trademarkia Logo

Canada

C$
Trademark Search in Canada
NEURIM PHARMACEUTICALS & DESIGN (COLOR)
NEURIM PHARMACEUTICALS & DESIGN (COLOR)
REGISTERED

on 3 Feb 2006

Last Applicant/ Owned by

NEURIM PHARMACEUTICALS (1991) LTD. AN ISRAELI LIMITED LIABILITY COMPANY

8 Hanechoshet St.69710 Tel Aviv

IL

Serial Number

1148499 filed on 31st Jul 2002

Registration Number

TMA658019 registered on 3rd Feb 2006

Registration expiry Date

3rd Feb 2031

Correspondent Address

SMART & BIGGAR LP

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

NEURIM PHARMACEUTICALS & DESIGN (COLOR)

Trademark usage description

pharmaceutical preparations for the treatment of central nervous system conditions, namely, sleep disorders, epilepsy and other convulsive disorders, Read More

Vienna Information


3 . 7 . 9

Albatross, cormorants, gulls, pelicansAlbatros, cormorans, mouettes, pélicans

3 . 7 . 16

Birds in flight or with outspread wingsOiseaux en vol ou à ailes largement déployées

3 . 7 . 24

Birds or bats stylized or personifiedOiseaux ou chauves-souris stylisés ou personnifiés

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 7

Letters surmounted by a sign of disproportionate size -- Note: Includes, for instance, a letter i surmounted by a disproportionate dot, by a star or a flower.Lettres surmontées d'un signe de dimension disproportionnée -- Note: Comprend par exemple la lettre i surmontée d'un point disproportionné, d'une étoile ou d'une fleur.

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

29 . 1 . 3

GreenVert

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of central nervous system conditions, namely, sleep disorders, epilepsy and other convulsive disorders, anxiety, diabetic neuropathy, chemotherapy-induced neuropathy, diseases involving self-inducted inflammatory processes culminating in neuronal death, and drug-related neuropathy; pharmaceutical preparations for the treatment of central nervous system neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and fever and analgesia; pharmaceutical preparations for the treatment of central nervous system chronobiological-based disorders including jet lag, circadian sleep disorders such as delayed sleep syndrome and shift-work adjustments, and seasonal-related disorders including seasonal affective disorder (SAD); pharmaceutical preparations for the treatment of cardiovascular, gastroenterological, bone, respiratory, hormonal, diabetic, stomach, digestive, rheumatic and ocular disorders, for the treatment of headaches, anti-inflammatory agents, anti-infectives, antibiotics, and for treatment of oncological disorders; pharmaceutical preparations for the treatment of endocrinological disorders, namely, contraception and infertility, precocious puberty, premenstrual syndrome, hyperprolactinemia and growth hormone deficiency; pharmaceutical preparations for the treatment of dermatological disorders, namely, UV-erythema, atopic eczema, dermatitis, psoriasis and malignant melanoma; pharmaceutical preparations for the treatment of haematological disorders, namely, leukemia, lymphoma and thrombocytopenia; pharmaceutical preparations for the treatment of circulatory disorders, namely, stroke, coronary heart disease, hypertension and hypotension; pharmaceutical preparations for the treatment of muscular disorders, namely, chronic fatigue syndrome, inflammatory myopathies and duchenne muscular dystrophy; pharmaceutical preparations for the treatment of immune system disorders, namely, allergic diseases, encephalomyelitis, AIDS and autoimmune diseases; pharmaceutical preparations for the treatment of metabolic disorders, namely, hyperlipidemia, amyloidosis and diabetes mellitus; chemical preparations for medical purposes, namely, diagnostic reagents and preparations for clinical and medical laboratory use.


Classification kind code

11

Mark Details


Serial Number

1148499

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 26
on 10th May 2005
Approved
Submitted for opposition 15
on 12th Nov 2004
Correspondence Created
Submitted for opposition 15
on 31st Dec 2003
Correspondence Created
Submitted for opposition 15
on 17th Sept 2003
Correspondence Created
Submitted for opposition 22
on 13th Jun 2003
Search Recorded
Submitted for opposition 20
on 13th Jun 2003
Examiner's First Report
Submitted for opposition 90
on 16th Sept 2002
Clerical Correction
Submitted for opposition 31
on 26th Aug 2002
Formalized
Submitted for opposition 1
on 6th Aug 2002
Created
Submitted for opposition 30
on 31st Jul 2002
Filed